LiDCOrapid Preview at World Congress & Investor Day

04 March 2008

LiDCO Group Plc (AIM: LID), the cardiovascular monitoring company, announces that the Company's new product the LiDCOrapid Monitor, is being exhibited to customers for the first time at the 14th World Congress of Anaesthesiologists being held in Cape Town, South Africa from 2 to 7 March 2008.

This is first major international meeting where the LiDCOrapid product will be displayed. Supporting the product at the meeting will be a paper outlining the design concept and role in the management of risk surgery patients and a presentation from use of the product in surgery. Both the paper and presentation will be available on request from LiDCO.

Dr Terry O'Brien, CEO LiDCO Group commented:

'We are on track to release the LiDCOrapid Monitor for sale on time and as expected in the first quarter of our financial year. Feedback from the clinical user group in both the UK and USA has been excellent and highly supportive for the product's commercial potential. Our direct sales staff and distributors are excited that they will be able to sell this new surgery product in the very near future.'

 

Notes for Editors

LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of
minimally invasive, computer-based hemodynamic monitoring equipment and
disposables used primarily for the management of critical care and
cardiovascular risk hospital patients. Use of LiDCO's technology has been shown
to significantly reduce the complications (particularly infections) and costs
associated with major surgery. The technology was invented in the Department of
Applied Physiology based at St Thomas' Hospital, London. For more information
please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current
products are:

  • LiDCOplus and PulseCO monitors: computer-based platforms for displaying a
    range of real-time, continuous hemodynamic parameters including cardiac output,
    oxygen delivery and fluid volume (PPV% and SVV%).
  • LiDCO disposables: used in conjunction with the LiDCOplus Monitor to
    accurately determine cardiac output in a minimally-invasive manner.
  • LiDCOview is designed as a graphical display of historical LiDCOplus
    hemodynamic data. LiDCOview provides both the clinical researcher and the
    routine user with easy to view beat-to-beat hemodynamic data that was collected
    with the LiDCOplus.. LiDCOviewSE is the standard version of this tool and is
    available for free, allowing anyone to download and access data from the
    LiDCOplus. LiDCOviewPRO is the Professional version, allowing users to analyse,
    export and report the LiDCOplus data. A free trial of LiDCOviewPRO is available
    for evaluation purposes prior to purchase.
  • LiDCOlive - software product in development for the remote display of
    hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.

Distribution Network:

The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of speciality critical care and anesthesia distributors.

 

Back to News Releases